AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
After a subdued year, the holiday season is strong
74% of online shoppers, around 3.1 million people, are preparing…
Read more >Battle of the regions: these are the most popular dishes according to Hungarians
Five times the national average of Mexican food is consumed…
Read more >Business-tailored halls help SMEs develop and grow
RaktárAD, a logistics developer with a Belgian-Hungarian ownership background, has…
Read more >